Privacy Policy - MindMed

MIND MEDICINE MINDMED INC. [MMEDF: OTCQB]

1.55 0.30 (24.00%) 11/23/2020 Delayed 15 minutes

Open	$1.30	Daily Range	$1.29-$1.62
Prev. Close	$1.25	52 Week Range	$0.0833-$1.255
Volume	11,580,732

Quote Data Realtime

Inside Quote
Bid	Ask	Last Inside Change
$0.00 x 0 shares	$0.00 x 0 shares	11/24 6:00 AM EST

Level II Quote Montage

BID

ASK

MMID	Bid Price	Bid Size	Date/Time
cNITE	1.54	100	11/23
cETRF	1.54	100	11/23
cMCAP	1.49	100	06:18
cGTSM	1.46	4231	11/23
cMAXM	1.28	100	11/23
cLAFC	0.6572	1000	10/28
VALX	U		11/23
cPUMA	U		11/23
cJANE	U		11/23
cINTL	U		11/23
cCDEL	U		11/23
cCSTI	U		11/23

MMID	Ask Price	Ask Size	Date/Time
cGTSM	1.55	100	11/23
cNITE	1.55	100	11/23
cMCAP	1.55	100	06:18
cETRF	1.58	100	11/23
cINTL	1.85	651	11/23
cMAXM	2.29	100	11/23
cCSTI	2.55	100	11/23
cLAFC	3.02	100	11/20
cPUMA	3.02	100	11/23
VALX	U		11/23
cJANE	U		11/23
cCDEL	U		11/23

The quotes displayed here are published by market makers on the OTC Markets Group Inc. electronic inter-dealer quotation and trading system for OTC securities. Please see Terms of Service and Risk Warning for more information.

MMID - Market maker quotation published in OTC Link that meets the Inside market | MMID - Market maker quotation published in OTC Link | cMMID - Closed quote | Unpriced - Unpriced quote in OTC Link | MMIDu - Unsolicited market maker quotation published in OTC Link

MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities

MindMed Announces Q3 2020 Financial Results; Cash Reserves Total $37.8 million USD ($50.1 million CAD) Post October Financing

Psychedelic Drug Company MindMed Applies For Nasdaq Up-Listing

This Company is Working on A Drug that Will Make LSD Less Trippy

Psychedelics-Drug Startup Raises $24 Million Ahead of IPO